Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Tracking error happens when a fund deviates from its index due to replication method, fees, or liquidity. Grasp the causes to improve tracking.
22,885 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
When headlines hint at a fallout between two A-list friends, the impact isn’t just gossip. This article digs into the...
In uncertain times, reliable income matters. Learn why wide-moat dividend stocks hold steady, using Coca-Cola and Joh...
A long standing trading rule is gone, and it could change how millions of small investors trade. This shift may lift ...
A powerful shift is forming: auto plants turning into energy storage hubs to power data centers and grids. This unsto...
Chicago-based MLS operator MRED formally pushes to compel arbitration with Zillow, placing a spotlight on contract la...
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
As America reshapes its manufacturing landscape, rare earths play a pivotal role in magnets, EVs, and wind turbines. ...
As Apple schedules its July 30 earnings, a growing cohort of investors signals a core, long-horizon bet on cash gener...
Microsoft is reshaping its Xbox division with sweeping layoffs exceeding 3,000 workers, signaling a hard reset that c...
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Deere unveiled a $20 billion precision agriculture push over the next decade, blending hardware with software to rede...